POSA282 Oncology Drugs without Phase III Data: Comparison of Reimbursement Recommendations Issued by the Canadian Agency for Drugs and Technologies in Health (CADTH), and the National Institute for Health and Care Excellence (NICE)
Abstract
Authors
S Singh G Hachborn K Jarrett L Pericleous S Benyo M Maoloni